Firebrick Pharma Appoints New Director with Options Grant

Firebrick Pharma Limited ( (AU:FRE) ) has provided an update.

Firebrick Pharma Limited has announced the appointment of Rick Legleiter as a director, effective from August 1, 2025. As part of his appointment, Legleiter holds 1,000,000 unlisted options expiring on August 1, 2029, at an exercise price of $0.15. This appointment and the accompanying options grant are expected to align the new director’s interests with those of the company and its stakeholders, potentially impacting the company’s strategic direction and governance.

More about Firebrick Pharma Limited

Average Trading Volume: 74,945

Technical Sentiment Signal: Buy

Find detailed analytics on FRE stock on TipRanks’ Stock Analysis page.